Embelin reduces cutaneous TNF-α level and ameliorates skin edema in acute and chronic model of skin inflammation in mice

European Journal of Pharmacology

Volumn 662, Issue 1-3, 2011, Pages 63-69

  Kalyan Kumar, G ^a,c   Dhamotharan, R ^a   Kulkarni, Nagaraj M ^b   Mahat, Mahamad Yunnus A ^b   Gunasekaran, J ^a   Ashfaque, Mohammad ^c  

^a PRESIDENCY COLLEGE   (India)

^b K L E S S COLLEGE OF PHARMACY   (India)

^c Vanta Bioscience K2   (India)

Author keywords

Embelin; Psoriasis; Skin inflammation; TNF

Indexed keywords

CYTOKINE; EMBELIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC INFLAMMATION; CONTACT DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; SKIN EDEMA; SKIN INFLAMMATION; SKINFOLD THICKNESS; STRUCTURE ANALYSIS;

ACUTE DISEASE; ADULT; ANIMALS; BENZOQUINONES; CHRONIC DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; EAR DISEASES; EDEMA; FEMALE; HUMANS; INFLAMMATION; KERATINOCYTES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; SKIN DISEASES; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79957625650     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.04.037     Document Type: Article

References (19)

1. Ahn, K.S., Sethi, G., Aggarwal, B.B., 2007. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-κappaB (NF-κappaB) signaling pathway leading to suppression of NF-κappaB-regulated antiapoptotic and metastatic gene products. Mol. Pharmacol. 71, 209-219.
2. Bhandari, U., Kanojia, R., Pillai, K.K., 2002. Effect of ethanolic extract of Embelia ribes on dyslipidemia in diabetic rats. Int. J. Exp. Diabetes Res. 3, 159-162.
3. Burke, J.R., 2001. Targeting phospholipase A2 for the treatment of inflammatory skin diseases. Curr. Opin. Investig. Drugs 2, 1549-1552.
4. Chitra, M., Sukumar, E., Suja, V., Shyamala Devi, C.S., 1994. Antitumor, anti-inflammatory and analgesic property of embelin, a plant product. Chemotherapy 40, 109-113.
5. Chitra, M., Devi, C.S., Sukumar, E., 2003. Antibacterial activity of embelin. Fitoterapia 74, 401-403. (Pubitemid 36623308)
6. Delescluse, C., Vaigot, P., Bailly, J., Hensby, C.N., 1987. Effects of anti-inflammatory agents on edema and DNA synthesis induced by 12-O-tetradecanoylphorbol-13-acetate in the guinea pig. Agents Actions 21, 290-292. (Pubitemid 18019862)
7. Fantini, M., Pallone, F., 2008. Cytokines: from gut inflammation to colorectal cancer. Curr. Drug Targets 9, 375-380. (Pubitemid 352025211)
8. Grone, A., 2002. Keratinocytes and cytokines. Vet. Immunol. Immunopathol. 88, 1-12.
9. Hauser, C., Dayer, J.M., Jaunin, F., de Rochemonteix, B., Saurat, J.H., 1986. Intracellular epidermal interleukin 1-like factors in the human epidermoid carcinoma cell line A431. Cell. Immunol. 100, 89-96.
10. Kadoshima-Yamaoka, K., Murakawa, M., Goto, M., Tanaka, Y., Inoue, H., Murafuji, H., Hayashi, Y., Nagahira, K., Miura, K., Nakatsuka, T., Chamoto, K., Fukuda, Y., Nishimura, T., 2009. Effect of phosphodiesterase 7 inhibitor ASB16165 on development and function of cytotoxic T lymphocyte. Int. Immunopharmacol. 9, 97-102.
11. Kemeny, L., Michel, G., Dobozy, A., Ruzicka, T., 1994. Cytokine system as potential target for antipsoriatic therapy. Exp. Dermatol. 3, 1-8.
12. Kock, A., Schwarz, T., Kirnbauer, R., Urbanski, A., Perry, P., Ansel, J.C., Luger, T.A., 1990. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J. Exp. Med. 172, 1609-1614.
13. Krishnaswamy, M., Purushothaman, K.K., 1980. Antifertility properties of Embelia ribes: (Embelin). Indian J. Exp. Biol. 18, 1359-1360.
14. Kupper, T.S., Ballard, D.W., Chua, A.O., McGuire, J.S., Flood, P.M., Horowitz, M.C., Langdon, R., Lightfoot, L., Gubler, U., 1986. Human keratinocytes contain mRNA in distinguishable from monocyte interleukin 1 alpha and beta mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin 1. J. Exp. Med. 164, 2095-2100.
15. Nickoloff, B.J., Turka, L.A., 1993. Keratinocytes: key immunocytes of the integument. Am. J. Pathol. 143, 325-331.
16. Nickoloff, B.J., Karabin, G.D., Barker, J.N., Griffiths, C.E., Sarma, V., Mitra, R.S., Elder, J.T., Kunkel, S.L., Dixit, V.M., 1991. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am. J. Pathol. 138, 129-140.
17. Otuki, M.F., Vieira-Lima, F., Malheiros, A., Yunes, R.A., Calixto, J.B., 2005. Topical antiinflammatory effects of the ether extract from Protium kleinii and alpha-amyrin pentacyclic triterpene. Eur. J. Pharmacol. 507, 253-259.
18. Stanley, P.L., Steiner, S., Havens, M., Tramposch, K.M., 1991. Mouse skin inflammation induced by multiple topical applications of 12-O- tetradecanoylphorbol-13-acetate. Skin Pharmacol. 4, 262-271.
19. Ueda, H., Yamazaki, C., Yamazaki, M., 2004. A hydroxyl group of flavonoids affects oral anti-inflammatory activity and inhibition of systemic tumor necrosis factor-alpha production. Biosci. Biotechnol. Biochem. 68, 119-125.